GP0838B MM patients on DRd or VRg agents in the US

Global Patients is working with Evidera, a scientific research company, on behalf of a pharmaceutical company. We are conducting a study in people with multiple myeloma to understand their perspective of and preferences for multiple myeloma treatments. The study does not involve administration or testing of any treatments; we are only interested in opinions. We will not share any of your contact information without your permission. Collaboration is entirely voluntary, and results will remain anonymous and reported in aggregate.

Those interested and eligible will be invited to participate in a qualitative interview. We very much value and respect your time, so you will be compensated with $100 USD. 

If you have been diagnosed with multiple myeloma and are interested in participating or would like more information about the study, please contact me at:

Join this Study
Are you already a member of Global Patients?